Veru’s Compound Shows Promise as Antiviral/Anti-Inflammatory Therapeutic for Covid-19Anti-Inflammatory, Antigens, Antivirals, Cancer, Cell Signaling, Clinical Studies, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Coronavirus Infections, Cytokine Storm, Prostate Cancer, R&D, Therapeutics, University of TennesseeVeru Inc. is developing a dual anti-inflammatory/antiviral medication to combat severe Covid-19 infections. Read more August 11, 2020/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/08/Veru’s-Compound-Shows-Promise-as-AntiviralAnti-Inflammatory-Therapeutic-for-COVID-19-BioSpace-8-11-20.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2020-08-11 12:12:382020-08-11 20:11:24Veru’s Compound Shows Promise as Antiviral/Anti-Inflammatory Therapeutic for Covid-19
